These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 4771164)
1. [Methyldopa-induced thrombocytopenia]. Stenbaek O Tidsskr Nor Laegeforen; 1973 Dec; 93(34):2500-1. PubMed ID: 4771164 [No Abstract] [Full Text] [Related]
2. [Thrombocytopenia due to methyldopa]. Alkalay L Harefuah; 1975 Sep; 89(6):261-2. PubMed ID: 1165076 [No Abstract] [Full Text] [Related]
3. Impaired clot retraction in thrombocytopenia due to methyldopa. Polk OD; Kletter GG; Smith J; Castro O South Med J; 1982 Mar; 75(3):374-5. PubMed ID: 7063920 [TBL] [Abstract][Full Text] [Related]
4. Alpha-methyldopa-induced immune thrombocytopenia. Report of case. Marcus GJ; Stevenson M; Brown T Am J Clin Pathol; 1975 Jul; 64(1):113-5. PubMed ID: 1155367 [TBL] [Abstract][Full Text] [Related]
5. Methyldopa-induced thrombocytopenia in chronic lymphocytic leukemia. Shalev O; Brezis M N Engl J Med; 1977 Dec; 297(26):1471. PubMed ID: 927471 [No Abstract] [Full Text] [Related]
6. Methyldopa-induced reversible immune thrombocytopenia. Pai RG; Pai SM Am J Med; 1988 Jul; 85(1):123. PubMed ID: 3260451 [No Abstract] [Full Text] [Related]
7. Alpha methyldopa-induced autoimmune hemolytic anemia. Lergier JE; Maldonado N; Haddock J; Rivera E Bol Asoc Med P R; 1971 Jun; 63(6):134-7. PubMed ID: 5284389 [No Abstract] [Full Text] [Related]
8. Long-term treatment of hypertension with methyldopa. III. Tolerability. Caldwell JR; Metts JC J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672 [TBL] [Abstract][Full Text] [Related]
9. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL; Strocchi E; Ambrosioni E; Magnani B Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071 [TBL] [Abstract][Full Text] [Related]
10. Positive direct antiglobulin reactions and methyldopa. Klapper MS; Noto TA Ala J Med Sci; 1968 Jul; 5(3):421-7. PubMed ID: 5315985 [No Abstract] [Full Text] [Related]
12. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy. del Greco F; Huang CM; Quintanilla A J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673 [TBL] [Abstract][Full Text] [Related]
13. [Iatrogenic colitis induced by methyldopa]. Lichtenstein H; Henry R; Escure MN; Hautefeuille M; Wilhelm F Nouv Presse Med; 1980 Sep; 9(33):2349-50. PubMed ID: 7433030 [No Abstract] [Full Text] [Related]
14. A comparative study of metoprolol and methyldopa in the treatment of hypertension. Karachalios GN Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553 [TBL] [Abstract][Full Text] [Related]
16. Acute colitis with methyldopa. Graham CF; Gallagher K; Jones JK N Engl J Med; 1981 Apr; 304(17):1044-5. PubMed ID: 7207560 [No Abstract] [Full Text] [Related]
17. Methyldopa fever. Recurrence of symptoms with resumption of therapy. Klein HO; Kaminsky N N Y State J Med; 1973 Feb; 73(3):448-51. PubMed ID: 4510103 [No Abstract] [Full Text] [Related]
18. Prazosin and methyldopa in hypertension. Nanivadekar AS; Kulkarni SS Practitioner; 1981 Sep; 225(1359):1327-9. PubMed ID: 7031634 [No Abstract] [Full Text] [Related]
19. Methyldopa-induced auto-immune haemolytic anaemia-a report of two further cases. Ewing DJ; Hughes CJ; Wardle DF Guys Hosp Rep; 1968; 117(2):111-8. PubMed ID: 5678872 [No Abstract] [Full Text] [Related]